Skip to main content
Log in

Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis

  • Published:
Journal of Neural Transmission Aims and scope Submit manuscript

Summary.

To elucidate whether serum coenzyme Q10 levels are related with the risk for amyotrophic lateral sclerosis (ALS), we compared serum levels of coenzyme Q10 and the coenzyme Q10/cholesterol ratio, in 30 patients with ALS and 42 matched controls using a high performance liquid chromatography technique. The mean serum coenzyme Q10 levels and the coenzyme Q10/cholesterol ratio did not differ significantly between the 2 study groups. These values were not influenced by the clinical form (spinal vs. bulbar) of ALS, and they did not correlate with age, age at onset, and duration of the disease. These results suggest that serum coenzyme Q10 concentrations are unrelated with the risk for ALS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Received September 1, 1999; accepted January 4, 2000

Rights and permissions

Reprints and permissions

About this article

Cite this article

Molina, J., de Bustos, F., Jiménez-Jiménez, F. et al. Serum levels of coenzyme Q10 in patients with amyotrophic lateral sclerosis. J Neural Transm 107, 1021–1026 (2000). https://doi.org/10.1007/s007020070050

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s007020070050

Navigation